The latest price target for Equifax (NYSE:EFX) was reported by Exane BNP Paribas on December 16, 2024. The analyst firm set a price target for $305.00 expecting EFX to rise to within 12 months (a possible 17.99% upside). 42 analyst firms have reported ratings in the last year.

The latest analyst rating for Equifax (NYSE:EFX) was provided by Exane BNP Paribas, and Equifax upgraded their outperform rating.

The last upgrade for Equifax Inc happened on December 16, 2024 when Exane BNP Paribas raised their price target to $305. Exane BNP Paribas previously had a neutral for Equifax Inc.

The last downgrade for Equifax Inc happened on December 12, 2024 when Wolfe Research changed their price target from N/A to N/A for Equifax Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Equifax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Equifax was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.

While ratings are subjective and will change, the latest Equifax (EFX) rating was a upgraded with a price target of $0.00 to $305.00. The current price Equifax (EFX) is trading at is $258.50, which is within the analyst’s predicted range.